Former city employees filed a petition this week requesting the nation's top court address their case.

Two healthcare stocks offering above-average dividend yields, paired with valuations that appear underpriced relative to ...

Patient investors who buy the stock may be rewarded over the long term.

Q2 2026 shows a profitability inflection as TriLink scales IVT RNA/GMP enzymes and Cygnus adds recurring biologics safety ...

Moderna (MRNA) stock climbed 3.6% on melanoma vaccine trial success and COVID approval, but analysts remain cautious with $80 ...

I believe that one of the best ways for most people to invest in stocks is to buy well-diversified low-cost index funds.

The company is coming back into the spotlight thanks to recent developments.

BioVie Inc. ( BIVI ), a clinical-stage biopharmaceutical company, on Monday reported dosing the last patient in the Phase 2 ADDRESS-LC trial for Bezisterim in treating neurological symptoms of Long ...

EQT Corporation offers both upstream exposure and significant midstream diversification. Click here to read this latest ...

Novavax said Sanofi and Takeda received clearances for an updated Nuvaxovid formulation for the 2026-2027 COVID season.

Moderna Inc. (NASDAQ:MRNA) saw its share price soar by 156 percent in August—making it the highest-gaining stock for the ...